|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
-
Overview This study day will focus on important approaches to management of patients with secondary (or metastatic) breast cancer. Topics will include all aspects of the patient pathway, Including recent advances in systemic and local therapies for secondary breast cancer. There will also be sessions on the prevention and management of treatment toxicities. Target audience […]
£50 – £210.80
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
2 events,
-
An annual conference that brings together cancer researchers and stakeholders from across the UK. The Wales Cancer Research Conference is an opportunity for cancer researchers in Wales to convene across specialties, institutions and research areas. With speakers from Wales and the UK, presentations will cover the latest advances in cancer research, and opportunities to connect […]
-
Overview Advances in cancer treatments mean that more people are living longer, even with incurable disease. This has uncovered a need to review our approach to cancer pain management , ensuring that care is more personalised and consistent with the stage of disease. This course brings together expertise in the cancer pain field to provide […]
£50 – £200
|
0 events,
|
0 events,
|
0 events,
|
1 event,Overview This is a two day course which will present a basic understanding of cancer. Through a series of presentations David describes how cancer develops, the commonest types of cancer, cancer detection and treatment modalities. Intended Audience All those new to and in early careers in Oncology including Research, CTU, Admin support, Doctors, Nurses, AHP’s, […]
£285
|
2 events,The 9th DDR Inhibitors Summit returns to Boston in 2026 as the leading event uniting biopharma, biotech, and academia to advance next-generation DNA Damage Response (DDR)-targeted therapies beyond PARP. With growing clinical momentum for ATR, CHK1/2, WEE1, and DNA-PK inhibitors, this 3-day meeting delivers cutting-edge insights on biomarker-driven discovery, translational strategy, and combination approaches. Featuring […] |
1 event, |
1 event, |
0 events,
|
0 events,
|
0 events,
|
